Biotechnology

Transcenta Achieves Major Milestone in Continuous Perfusion Cell Culture Platform to Provide Industry Leading Productivity and Speed to Manufacturing

SUZHOU and HANGZHOU, China, Feb. 18, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D, regulatory affairs and manufacturing, today announced it has achieved a major milestone in its continuous perfusion cell cult...

2020-02-19 00:00 750

WuXi AppTec China Sites Resume Operations after Extended Lunar New Year Holiday

SHANGHAI, Feb. 12, 2020 /PRNewswire/ -- With the end of the extended Lunar New Year holiday, WuXi AppTec sites inChina have resumed operations today, with the exception of our site inWuhan, which will reopen when local regulations permit. These steps are being taken in compliance with disease con...

2020-02-12 20:00 1403

Origin Agritech Updates GMO Corn Seed Research and Commercialization Strategies

BEIJING, Feb. 10, 2020 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today updates the progress of biotech research programs and strategies for the commercialization of GMO corn seeds and traits.   As the ...

2020-02-10 21:00 4830

Alterity Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement

MELBOURNE, Australia and SAN FRANCISCO, Feb. 7, 2020 /PRNewswire/ -- Alterity Therapeutics Limited (ASX:ATH, NASDAQ:ATHE) has received notification from the Listing Qualifications Department of NASDAQ advising the Company that it is currently non-compliant with NASDAQ's requirement that listed se...

2020-02-07 21:00 11621

Human Breast Milk Breakthrough by TurtleTree Labs

SINGAPORE, Feb. 7, 2020 /PRNewswire/ -- TurtleTree Labs sets to showcase the world's first human breast milk using cell-based technology at theirApril 21, 2020 Future of Clean Milk launch. Coming off from a successful funding round, the team has brought on world class scientists likeJonathan Loh ...

2020-02-07 15:00 1954

Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director

HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...

2020-02-06 19:30 7045

Bridge Biotherapeutics Acquires a New Drug Development Candidate for Back-Eye Diseases

* Signed a collaboration and license agreement for developing back-eye disease treatments with Konkuk University in the Republic of Korea * A total of 10B KRW deal includes 300M KRW of upfront payment SEONGNAM, South Korea, Feb. 5, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical ...

2020-02-05 13:21 1147

Sales of Cordyceps Mycelia Products Surged over 100% in January

NANPING, China, Jan. 28, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the sales of its Cordyceps mycelia products surged over 100% in January due to the outbreak ...

2020-01-28 22:09 8981

Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody

SUZHOU and HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D and manufacturing of antibody-based therapeutics, announces today that an investigational new drug (IND) appl...

2020-01-21 00:00 908

Milk without the cow: TurtleTree Labs, world's first company producing milk from cells, secures pre-seed funding

* The pre-seed round was led by Lever VC with K2 Global and KBW Ventures backing TurtleTree Labs * TurtleTree is the world's first company using technology to create real milk from animal cells, with no animal needed. * The raise will be used to onboard more scientists to the TurtleTree team...

2020-01-20 15:37 2129

Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC

SEONGNAM, South Korea, Jan. 19, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration (FDA) has been cleared ...

2020-01-20 10:44 1213

Happiness Biotech Group Limited Announces Financial Results for the Six Months Ended September 30, 2019

NANPING, China, Jan. 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months endedSeptember 30, 2019. The financial results...

2020-01-17 21:00 19123

GenScript and Genopis Enter Into Strategic Partnership Agreement for Manufacture Service of GMP Plasmids

NANJING, China, Jan. 15, 2020 /PRNewswire/ -- On January 14, 2020, at San Francisco, USA, a global leading biotech company GenScript announced that it signed a strategic partnership agreement for the manufacturing service of GMP Plasmids with Genopis, Inc., a company that specializes in plasmid D...

2020-01-16 01:00 2054

WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform

PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advance therapies industry, announced today the expansion of its service capabilities by offering a fully ...

2020-01-13 22:00 6477

WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

* The 12th global licensing partnership for WuXiBody™ since its launch in August 2018 showcasing the power and versatile applications of WuXiBody™ in multiple therapeutic areas SHANGHAI and BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global o...

2020-01-09 17:10 2607

Transcenta Holding Secures $100 Million Series B Plus Financing

HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a 100 millio...

2020-01-08 21:00 1521

Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies

SUZHOU, China and SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed usingTruUCAR™ to treat relapsed or refr...

2020-01-07 22:00 1040

Beta Lifescience Announces the Online Availability of Quality Immune Checkpoint Proteins for Scientific Discoveries

FIREFILED, N.J., Jan. 7, 2020 /PRNewswire/ -- Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the...

2020-01-07 21:10 832

Transcenta to Present at the 38th Annual J.P. Morgan Healthcare Conference

HONG KONG, SUZHOU, China and HANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- Transcenta Holding (Transcenta) today announced that Co-founder & CEO Dr. Xueming Qian will present at the 38th Annual J.P. Morgan Healthcare Conference onWednesday, January 15, 2020, at 14:30 PST in Golden Gate room at Wes...

2020-01-07 00:00 1296

I-Mab Biopharma Announces Dosing of First Patient in a Pivotal Study of TJ202/MOR202 in Multiple Myeloma in Mainland China

SHANGHAI, Jan. 3, 2020 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based inChina and the United States and focused on the discovery and development of novel or highly differentiated biologics in immuno-oncology and autoimmune diseases today announced the dosing o...

2020-01-04 00:07 1943